Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01292629 · ClinicalTrials.gov registry record · NA

Comparison of the Hoya Surgical Optics (HSO) iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls.

A NA study of Cataract and Aphakia, sponsored by Hoya Surgical Optics.

Completed
Registry status
NA
Development phase
125
Enrollment target
5
Study locations

NCT01292629 is a NA study of Cataract and Aphakia that has completed, run by Hoya Surgical Optics. The registered enrollment target is 125 participants, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (45% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01292629, a NA study of Cataract and Aphakia, has completed, sponsored by Hoya Surgical Optics.

COMPLETED
Registry status
NA
Development phase
125 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this multi-center clinical trail is to determine the safety and efficacy of the iSert 251 for the correction of aphakia.

Conditions Studied

Interventions

  • DEVICE iSert 251 intraocular lens

Study Locations (5)

Florida

  • Katzen Eye Care and Laser Center - Boynton Beach
  • Center for Excellence in Eye Care - Miami

Arizona

  • Schwartz Laser Eye Center - E. Shea Blvd, Suite C101

Indiana

  • Eye Surgeons of Indiana - Indianapolis

Massachusetts

  • Eye Health Vision Centers - North Dartmouth

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2011-02
Est. Completion 2012-05
Phase NA

Sponsor

Hoya Surgical Optics

3 total trials

What the Registry Record Tells You About NCT01292629

The ClinicalTrials.gov registry entry for NCT01292629 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (45% lower). The listed sponsor is Hoya Surgical Optics, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which iSert 251 intraocular lens is the first listed.

NCT01292629 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Florida, Arizona, Indiana.

Frequently Asked Questions

What is clinical trial NCT01292629 about?

NCT01292629 is a clinical study titled "Comparison of the Hoya Surgical Optics (HSO) iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls.". The purpose of this multi-center clinical trail is to determine the safety and efficacy of the iSert 251 for the correction of aphakia.

What is the current status of trial NCT01292629?

This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2011-02. Estimated completion is 2012-05.

What conditions does trial NCT01292629 study?

This clinical trial studies the following conditions: Cataract, Aphakia.

What interventions are being tested in trial NCT01292629?

The interventions under investigation include: iSert 251 intraocular lens (DEVICE).

Who is sponsoring clinical trial NCT01292629?

This trial is sponsored by Hoya Surgical Optics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01292629 being conducted?

This trial has 5 study locations across Arizona, Florida, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.